Real-time enrollment status for this advanced/metastatic non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 6:22 AM UTC
| NCT Number | NCT07227298 |
| Recruiting Status | Recruiting |
| Condition | Advanced/Metastatic Non-Small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 162 participants |
| Active Locations | 36 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of August 28, 2026: Clinical trial NCT07227298 is currently recruiting participants. This phase1 study for advanced/metastatic non-small cell lung cancer is actively seeking new participants at 36 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07227298 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07227298 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.